Oracle's Larry Ellison Cancels $7.5 Bln Stock Sale Plan

Oracle Corp. (ORCL) announced that Larry Ellison, its Chairman and CTO, canceled plans to sell 50 million shares worth $7.5 billion. The company stated no shares were sold under the 10b5-1 plan and Ellison has no further plans to sell his Oracle stock.

Original reporting
Published Sep 13, 2026, 5:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 13, 2026, 5:48 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$ORCL
Bullish
medium confidence
Mentioned
$ORCL
Relevance
8/10
AlphAI data visualization · based on rttnews.com
Decision brief

The 30-second read

$ORCLBullishLow
01

Why it matters

The news removes a potential large‑scale share dilution, which could be viewed positively by investors.

02

Market read

Cancellation of a $7.5 bn insider sell‑off is a notable corporate action that may modestly support Oracle's stock.

03

What to watch

Potential tax or regulatory considerations behind the reversal are not disclosed.

Relevance 8/10Novelty 8/10Timing: today

Background

Oracle announced the cancellation after a 10b5‑1 plan filing showed no shares had been sold.

Company-level read

Ticker impact

$ORCLBullishMedium confidence
Context

Larry Ellison cancelled a planned sale of up to 50 million Oracle shares worth $7.5 billion.

Expected impact

Potential modest upside as supply pressure eases.

Evidence & confidence

The cancellation eliminates a $7.5 bn sell‑off that could have depressed the stock; no new dilution or capital raise is introduced.

Market effects

May slightly improve sentiment for the enterprise‑software sector by removing a large insider sell‑off.

Primarily U.S. market effect; limited global ripple.

Low; impact confined to Oracle and its peers.

Counterpoint

The cancellation may be a temporary measure; Ellison could still sell later, so price impact could be muted.

Key entities

  • Larry Ellison

    Chairman and CTO of Oracle, original seller of the planned shares.

  • Oracle Corp.

    U.S. enterprise‑software giant (ticker ORCL).

Related articles

$ORCLLow

Congressman Hamadeh Reprimands Oracle Executives Over $27B Failure to Deliver Working VA Health Record System

Congressman Abe Hamadeh criticized Oracle executives during a House Committee hearing over the company's $27 billion VA health record system contract, which has seen limited implementation. Hamadeh demanded accountability and justification for cost increases, citing a lack of progress and value for taxpayers. Oracle CEO Mike Sicilia testified after being subpoenaed.

$ORCLMed

Oracle Says OpenAI Compute Contract Is Fully Funded After $20 Billion Capital Raise — BigGo Finance

Oracle announced its cloud infrastructure contract with OpenAI is fully funded after a $20 billion capital raise. The company aims to achieve positive free cash flow by H2 FY2028 and $30 billion annually by FY2029. Oracle shares rose 3.3% in after-hours trading. The company also confirmed its Abilene, Texas campus is nearly complete and plans 4.5 gigawatts of additional U.S. data-center capacity with OpenAI.

$ORCLMed

Oracle Says It Has Funding Secured for OpenAI Infrastructure Contract

Oracle announced on Nov. 20 that it has secured all necessary funding for its OpenAI infrastructure contract, including $19.9 billion from recent stock and note offerings. The company plans to limit additional capital-market funding to $20 billion for its fiscal 2027–2030 investment cycle, with positive free cash flow expected from the second half of fiscal 2028. Oracle's shares rose as much as 3.3% in after-hours trading following the news.